3Schiemann-Delgado J, Yang H, Loge Cde L, ct al. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures[J]. Child Neurol, 2012, 27(1): 80-89.
4Popov IV, Iakovleva IA. Dynamics of cognitive and emotional- volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2013, 3 (5): 48-52.
5Faa G, Ekstrom J, Castagnola M, et al. A developmental approach to drug-induced liver injury in newborns and children[J]. Curr Med Chem, 2012, 19(27): 4581-4594.
6Sivkova SN, Mukhin KIuj Zaikova FM. Efficacy of treatment of focal forms of epilepsy in children with antiepileptic drugs of different generations[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2011, 11(6): 42-48.
7Tumay Y, Mtun Y, Ekmekci K, et al. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients [J]. Clin Neuropharmacol, 2013, 6 (2): 55-58.
8Zhou JQ Zhou LM, Chen LJ, et al. Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women[J]. Seizure, 2012, 1(9): 729-733.
9Hu X, Wang J, Dong W, et al. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy[J].Epilepsy Res, 2011, 97(1-2): 73-82.
10De Smedt T, Raedt R, Vonck K, et al. Levetiracetam: part Ⅱ, the clinical profile of a novel anticonvulsant drug[J]. CNS Drug Rev, 2007, 3(1): 57-78.
